Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs
- PMID: 17275314
- DOI: 10.1016/j.bmc.2007.01.011
Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs
Abstract
Matrix metalloproteinases (MMPs) are a large family of calcium-dependent zinc-containing endopeptidases, which are responsible for the tissue remodeling and degradation of the extracellular matrix (ECM), including collagens, elastins, gelatin, matrix glycoproteins, and proteoglycan. They are regulated by hormones, growth factors, and cytokines, and are involved in ovarian functions. MMPs are excreted by a variety of connective tissue and pro-inflammatory cells including fibroblasts, osteoblasts, endothelial cells, macrophages, neutrophils, and lymphocytes. These enzymes are expressed as zymogens, which are subsequently processed by other proteolytic enzymes (such as serine proteases, furin, plasmin, and others) to generate the active forms. Matrix metalloproteinases are considered as promising targets for the treatment of cancer due to their strong involvement in malignant pathologies. Clinical/preclinical studies on MMP inhibition in tumor models brought positive results raising the idea that the development of strategies to inhibit MMPs may be proved to be a powerful tool to fight against cancer. However, the presence of an inherent flexibility in the MMP active-site limits dramatically the accurate modeling of MMP-inhibitor complexes. The interest in the application of quantitative structure-activity relationships (QSARs) has steadily increased in recent decades and we hope it may be useful in elucidating the mechanisms of chemical-biological interactions for this enzyme. In the present review, an attempt has been made to explore the in-depth knowledge from the classification of this enzyme to the clinical trials of their inhibitors. A total number of 92 QSAR models (44 published and 48 new formulated QSAR models) have also been presented to understand the chemical-biological interactions. QSAR results on the inhibition of various compound series against MMP-1, -2, -3, -7, -8, -9, -12, -13, and -14 reveal a number of interesting points. The most important of these are hydrophobicity and molar refractivity, which are the most important determinants of the activity.
Similar articles
-
Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1927-1939. doi: 10.1016/j.bbamcr.2017.06.009. Epub 2017 Jun 19. Biochim Biophys Acta Mol Cell Res. 2017. PMID: 28636874 Review.
-
Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results.Curr Med Chem. 2005;12(3):339-55. doi: 10.2174/0929867053363243. Curr Med Chem. 2005. PMID: 15723623 Review.
-
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.Cells. 2020 May 25;9(5):1313. doi: 10.3390/cells9051313. Cells. 2020. PMID: 32466129 Free PMC article. Review.
-
Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.Mol Cell Endocrinol. 2002 May 31;191(1):45-56. doi: 10.1016/s0303-7207(02)00054-0. Mol Cell Endocrinol. 2002. PMID: 12044918 Review.
-
Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.Nat Rev Cancer. 2006 Mar;6(3):227-39. doi: 10.1038/nrc1821. Nat Rev Cancer. 2006. PMID: 16498445 Review.
Cited by
-
Association of matrix metalloproteinases (MMPs) gene polymorphisms with periodontitis: a systematic review.GMS Hyg Infect Control. 2024 Oct 23;19:Doc53. doi: 10.3205/dgkh000508. eCollection 2024. GMS Hyg Infect Control. 2024. PMID: 39553301 Free PMC article. Review.
-
Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets.Cells. 2024 Sep 19;13(18):1574. doi: 10.3390/cells13181574. Cells. 2024. PMID: 39329757 Free PMC article. Review.
-
Effects of Isoxazolyl Steroids on Key Genes of Sonic Hedgehog Cascade Expression in Tumor Cells.Molecules. 2024 Aug 26;29(17):4026. doi: 10.3390/molecules29174026. Molecules. 2024. PMID: 39274874 Free PMC article.
-
Evaluation of the clinical efficacy of Ru'ai Shuhou recipe for the prevention of lung metastases from breast cancer: a retrospective study based on propensity score matching.Front Pharmacol. 2024 Aug 2;15:1406862. doi: 10.3389/fphar.2024.1406862. eCollection 2024. Front Pharmacol. 2024. PMID: 39156102 Free PMC article.
-
Fatty acid metabolism-related enzymes in colorectal cancer metastasis: from biological function to molecular mechanism.Cell Death Discov. 2024 Aug 5;10(1):350. doi: 10.1038/s41420-024-02126-9. Cell Death Discov. 2024. PMID: 39103344 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases
Miscellaneous